Navigation Links
Synthetic biology: Is ethics a showstopper?
Date:12/3/2008

WASHINGTON Synthetic biology promises to enable cheap, lifesaving new drugs to treat the 350-500 million people who suffer from malaria, and to create innovative biofuels that can help solve the world's energy problems. But the science and its applications are raising questions: Are synthetic biologists playing God? Are these scientists purposely changing the definition of what is life? Are synthetic biology researchers unintentionally equipping terrorists with frightening new biological weapons? And will synthetic biology's expected products and profits be stymied by policymakers and the public who object to researchers' soon-to-be-realized attempts to build life from scratch in a lab?

Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania, will explore unresolved synthetic biology ethical questions at a January 8 program with Project on Emerging Nanotechnologies Chief Science Advisor Andrew Maynard. Dr. Caplan is at the forefront of ethicists, theologians, scientists, engineers, government leaders and civil society groups working to weigh synthetic biology's potential risks and benefits.

Caplan is the author or editor of 25 books and over 500 articles in professional medical, science and bioethics journals. He has served on a number of national and international committees including as chair of the National Cancer Institute Biobanking Ethics Group, and chair of the Advisory Committee to the United Nations on Human Cloning. His most recent book is Smart Mice, Not So Smart People (Rowman Littlefield, 2006).

The Rathenau Instituut, a unit of the Royal Netherlands Academy of Arts and Sciences (KNAW), describes synthetic biology as the convergence of molecular biology, information technology and nanotechnology, leading to the systematic design of biological systems. The U.S. is considered the world leader in this emerging field of science. Some estimate that by 2015, a fifth of the chemical industry (worth $1.8 trillion) could be dependent on synthetic biology.

To attend this event, RSVP to nano@wilsoncenter.org. No RSVP is required to view the Web cast.

*** Web cast LIVE at www.wilsoncenter.org ***

What: Synthetic Biology: Is Ethics a Showstopper?

When: Thursday, January 8, 2009, 12:30 1:30 PM (Light lunch available at 12 noon.)

Who: Arthur Caplan, Ph.D., Chair, Department of Medical Ethics and Director, Center for Bioethics, University of Pennsylvania
Andrew Maynard, Ph.D., Chief Science Advisor, Project on Emerging Nanotechnologies, Moderator

Where: Woodrow Wilson International Center for Scholars, 5th Floor Conference Room in the Ronald Reagan Building at 1300 Pennsylvania Avenue, NW, Washington, DC. For directions see: http://www.wilsoncenter.org/directions


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues
2. Synthetic compound promotes death of lung-cancer cells, tumors
3. Experts from Stevens, Merck, publish joint paper, Biosynthetic Studies of Platensimycin
4. Researchers decode genetics of rare photosynthetic bacteria
5. Researchers decode genetics of rare photosynthetic bacterium
6. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
7. Berkeley researchers identify photosynthetic dimmer switch
8. Oregano oil works as well as synthetic insecticides to tackle common beetle pest
9. New projects to raise UK profile in synthetic biology
10. Synthetic Biology: funders move to address social and ethical challenges
11. Synthetic cocoa chemical slows growth of tumors in human cell lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... Research and Markets has announced the addition ... their offering. ... tracking market to grow at a CAGR of 30.37% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon ... awards honoring scientists who have made outstanding contributions to analytical chemistry ... Pittcon 2018, the world’s leading conference and exposition for laboratory science, which will ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
Breaking Biology Technology: